In this study, we have shown that in the early stages of SARS-CoV-2 infection there is a significant increase in serum HMGB1 levels compared with uninfected subjects, suggesting a pathological link between HMGB1 and COVID-19. This evidence concerns the gene HMGB1 and COVID-19.